Navigation Links
Smith & Nephew Endoscopy Launches the FOOTPRINT PK Suture Anchor for Shoulder Repair
Date:4/24/2008

Enables surgeons to adjust suture tension during bridging procedures

ANDOVER, Mass., April 24 /PRNewswire-FirstCall/ -- Smith & Nephew's (NYSE: SNN; LSE: SN) Endoscopy Division today announced the launch of the FOOTPRINT PK Suture Anchor, a system used to attach rotator cuff tissue to bone in the shoulder. The anchor is among products featured at the Arthroscopy Association of North America (AANA) Spring Meeting, which began today in Washington, D.C.

The objective during rotator cuff repair is to return the soft tissue to its original anatomic attachment site. Unlike early single row suture anchor techniques, which employed single-point re-attachment, the "footprint repair" approach uses multiple anchors in two rows, often with suture bridges that provide greater tissue-to-bone attachment (see attached).

Early approaches to cuff repair included transosseous tunnel repairs, which are still done today in some medical practices. During this procedure, the surgeon drills bone tunnels through the humeral head and laces suture through them. Smith & Nephew Endoscopy's FOOTPRINT PK Suture Anchor delivers a Transosseous Equivalent (TOE) repair without the need for drilling transosseous bone tunnels.

Its two-piece design allows for the shell of the anchor to be tapped into place. Then, independent of implantation, an inner plug is advanced, which secures the sutures running from the other anchor rows.

"The FOOTPRINT PK Suture Anchor enables surgeons to precisely apply the desired amount of suture tension that is necessary to maximize the construct strength on a case-by-case basis," said Dr. Nikhil Verma, an orthopaedic surgeon and sports medicine specialist at Midwest Orthopaedics at Rush University Medical Center in Chicago. "The suture tension can be adjusted even after the anchor is implanted."

The anchor design enables the surgeon to adjust the tension of the suture bridges, so the final fixation is set exactly as the surgeon wishes. Unlike anchors where the tension is set before anchor implantation, the surgeon knows exactly how much tension is present upon completion.

"In designing the FOOTPRINT PK Suture Anchor, our engineers listened to the concerns of surgeons who want to preserve healthy tissue, achieve optimal fixation and help their patients resume the activities they enjoy," said Mike Frazzette, President of Smith & Nephew Endoscopy. "We are pleased to showcase this device during the AANA Meeting, where we are able to demonstrate the technology to so many of our surgeon customers."

Contact: Joe Metzger

Vice President, Corporate Communications

Smith & Nephew Endoscopy

(978) 749-1330

joe.metzger@smith-nephew.com

About Us

Smith & Nephew is a global medical technology business, specialising in Orthopaedic Reconstruction, Orthopaedic Trauma and Clinical Therapies, Endoscopy and Advanced Wound Management products. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were nearly $3.4 billion.

Forward-Looking Statements

This press release contains certain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. In particular, statements regarding planned growth in our business and in our operating margins discussed under "Outlook" are forward-looking statements as are discussions of our product pipeline. These statements, as well as the phrases "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions, are generally intended to identify forward-looking statements. Such forward- looking statements involve known and unknown risks, uncertainties and other important factors (including, but not limited to, the outcome of litigation and regulatory approvals) that could cause the actual results, performance or achievements of Smith & Nephew, or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Please refer to the documents that Smith & Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith & Nephew's most recent annual report on Form 20F, for a discussion of certain of these factors.

All forward-looking statements in this press release are based on information available to Smith & Nephew as of the date hereof. All written or oral forward-looking statements attributable to Smith & Nephew or any person acting on behalf of Smith & Nephew are expressly qualified in their entirety by the foregoing. Smith & Nephew does not undertake any obligation to update or revise any forward-looking statement contained herein to reflect any change in Smith & Nephew's expectation with regard thereto or any change in events, conditions or circumstances on which any such statement is based.


'/>"/>
SOURCE Smith & Nephew Endoscopy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
2. Law Offices of Howard G. Smith Announces 21 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Vertex Pharmaceuticals Inc.
3. Correction: Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Inverness Medical Innovations, Inc.
4. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
5. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Merck & Co., Inc. Who Invested in the Merck & Co., Inc. Employee Savings and Security Plan
6. GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
7. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of WellPoint, Inc. Who Invested in the WellPoint Retirement Savings Plan
8. Former NYPD and Suffolk County Parks Officer, Who Responded to 9/11, to Receive Power Scooter From The SCOOTER Store at Benefit Event in Smithtown
9. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
10. Reps. Smith and Doyle, Autism Society of America Push Landmark Legislation on World Autism Awareness Day
11. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Vail knee specialist ... Leaders to Know in 2016 . The list consists of physicians establishing, leading and ... establish this list. , An Ambulatory Surgery Center, also known as an ASC, ...
(Date:2/12/2016)... ... 12, 2016 , ... Miami Dental Specialists is excited to bring patients the ... Beginning in January, Miami Dental Specialists will offer the non-metal implants as a safe, ... to be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge technology ...
(Date:2/12/2016)... Grants Pass, OR (PRWEB) , ... February 12, ... ... website contains an article about foods choices that promote eye health. These articles ... optimal vision health. Water and health advocate Sharon Kleyne endorses every one of ...
(Date:2/12/2016)... ... February 12, 2016 , ... A lot has been reported about the ... has access to health and wellness resources most Americans could ever dream of having ... has a schedule as frenetic as the U.S. President. , In honor of ...
(Date:2/12/2016)... Texas (PRWEB) , ... February 12, 2016 , ... Yisrayl ... a revealing article this week that uncovers what he says are the real facts ... stories of the Bible from parents and Sunday school teachers, and Yisrayl says there ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... 11, 2016 Stem cells are primitive cells ... self-renewal and the capacity to differentiate into mature cell ... as the first mouse embryonic stem cells were derived ... 1995 that the first culturing of embryonic stem cells ... not produced until 2006 As a result of these ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology: